Publikationen und Patente 2021

2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

 

  1. Álvarez I, Diez-Fairen M, Aguilar M, González JM, Ysamat M, Tartari JP, Carcel M, Alonso A, Brix B, Arendt P, Pastor P. Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia. Eur J Neurol 28(4):1142-1152 (2021).
  2. Bogdanos DP, Gkoutzourelas A, Papadopoulos V, Liaskos C, Patrikiou E, Tsigalou C, Sarantziotis A, Hajiioannou J, Scheper T, Meyer W, Sakkas LI, Papandreou C. Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer. Clin Chim Acta 521:199-205 (2021)
  3. Brändle SM, Cerina M, Weber S, Held K, Menke AF, Alcalá C, Gebert D, Herrmann AM, Pellkofer H, Gerdes LA, Bittner S, Leypoldt F, Teegen B, Komorowski L, Kümpfel T, Hohlfeld R, Meuth SG, Casanova B, Melzer N, Beltrán E, Dornmair K. Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis. Proc Natl Acad Sci USA 118(9):e1916337118 (2021).
  4. Brasch J, Beck-Jendroschek V, Voss K, Achenbach A, Berger HG, Harder M, Gräser Y, Schwarz T. Arthroderma crocatum auf menschlicher Haut. Hautarzt 3 (2021).
  5. Dolscheid-Pommerich R, Bartok E, Renn M, Kümmerer BM, Schulte B, Schmithausen RM, Stoffel-Wagner B, Streeck H, Saschenbrecker S, Steinhagen K, Hartmann G. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity. J Med Virol doi: 10.1002/jmv.27287 (2021).
  6. Emmerich P, von Possel R, Deschermeier C, Ahmeti S, Berisha L, Halili B, Jakupi X, Sherifi K, Messing C, Borchardt-Lohölter V. Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever. PloS Negl Trop Dis 15(3):e0009280 (2021).
  7. Emmerich P, von Possel R, Hemmer CJ, Fritzsche C, Geerdes-Fenge H, Menge B, Messing C, Borchardt-Lohölter V, Deschermeier C, Steinhagen K. Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods. J Med Virol 93(10):5816-5824 (2021).
  8. Emtenani S, Ghorbanalipoor S, Mayer-Hain S, Kridin K, Komorowski L, Probst C, Hashimoto T, Pas HH, Męcińska-Jundziłł K, Czajkowski R, Recke A, Sunderkötter C, Schneider SW, Hundt JE, Zillikens D, Schmidt E, Ludwig RJ, Hammers CM. Pathogenic Activation and Therapeutic Blockage of Fc Alpha Receptor-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus. J Invest Dermatol S0022-202X(21)01412-3 (2021).
  9. Hansson O, Batrla R, Brix B, Carrillo MC, Corradini V, Edelmayer RM, Esquivel RN, Hall C, Lawson J, Bastard NL, Molinuevo JL, Nisenbaum LK, Rutz S, Salamone SJ, Teunissen CE, Traynham C, Umek RM, Vanderstichele H, Vandijck M, Wahl S, Weber CJ, Zetterberg H, Blennow K. The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau. Alzheimers Dement 17(9):1575-1582 (2021).
  10. Haubold B, Klötzl F, Hellberg L, Thompson D, Cavalar M. Fur: Find Unique Genomic Regions for Diagnostic PCR. Bioinformatics btab059 (2021).
  11. Hoxha E, Stahl RAK, Reinhard L, Kühnl A, Schlumberger W, Dähnrich C. A new chemiluminescence immunoassay for phospholipase A2 receptor 1 autoantibodies allows early identification of autoantibody recurrence in patients with membranous nephropathy. Kidney Int Rep 6(4):928-935 (2021).
  12. Jarius S, Wilken D, Haas J, Ruprecht K, Komorowski L, Wildemann B. Parvovirus B19 and mumps virus antibodies are major constituents of the intrathecal immune response in European patients with MS and increase the diagnostic sensitivity and discriminatory power of the MRZ reaction. J Neurol 268(10):3758-3765 (2021).
  13. Knight V, Askar MZ, Ntrivalas E, Nandiwada SL, Peterson LK, Tebo AE, Kadkhoda K, Schmitz JL, Naides SJ, Snyder MR, Sadighi Akha AA. Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI). J Immunol Methods 492:112994 (2021).
  14. Markewitz R, Pauli D, Dargvainiene J, Steinhagen K, Engel S, Herbst V, Zapf D, Krüger C, Sharifzadeh S, Schomburg B, Leypoldt F, Rupp J, Görg S, Junker R, Wandinger KP. The temporal course of T- and B-cell-responses to vaccination with BNT162b2 and mRNA-1273. Clin Microbiol Infect S1198-743X(21)00496-1 (2021).
  15. Marzahl C, Aubreville M, Bertram CA, Maier J, Bergler C, Kröger C, Voigt J, Breininger K, Klopfleisch R, Maier A. EXACT: a collaboration toolset for algorithm-aided annotation of images with annotation version control. Sci Rep 11(1):4343 (2021).
  16. Miske R. What do we know about autoantibodies against the novel Purkinje cell antigen DAGLA? AACC Academy Scientific Shorts. May 18, 2021.
  17. Miske R, Scharf M, Stark P, Dietzel H, Bien CI, Borchers C, Kermer P, Ott A, Denno Y, Rochow N, Borowski K, Finke C, Teegen B, Probst C, Komorowski L. Autoantibodies against the Purkinje cell protein RGS8 in paraneopastic cerebellar syndrome. Neurol Neuroimmunol Neuroinflamm 8(3):e987 (2021).
  18. Naides SJ. Dr. Naides reply. J Rheumatol 48(7):1190 (2021).
  19. Niederhauser C, Tinguely C, Dreier J, Vollmer T, Marti HP, Nichkel B, Klemens JM, Warnecke JM, Gowland P. Comparison of a new IgG-EIA for the detection of anti-Plasmodium antibodies with two currently used assays. Transfus Med Hemother 48:265-271 (2021).
  20. Raulf M, Jordan D, Auer H, Warnecke J, Lepenies B, Strube C. A new ELISA and western blot technique based on recombinant TES antigen and/or larval antigen for the detection of toxocariasis in humans. Parasitology 148(3):333-340 (2021).
  21. Reinhard L, Thomas C, Machalitza M, Lattwein E, Weiss LS, Vitu J, Wiech T, Stahl RAK, Hoxha E. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy. Sci Rep 11(1):16188 (2021).
  22. Rietveld A, Wienke J, Visser E, Vree Egberts W, Schlumberger W, van Engelen B, van Royen-Kerkhof A, Lu H, Wedderburn L, Saris C, Tansley S, Pruijn G; Juvenile Dermatomyositis Research Group and Dutch Myositis Consortium. Anti-cytosolic 5’-nucleotidase 1A autoantibodies are absent in juvenile dermatomyositis. Arthritis Rheumatol 73(7):1329-1333 (2021).
  23. Schanda K, Peschl P, Lerch M, Seebacher B, Mindorf S, Ritter N, Probst M, Hegen H, Di Pauli F, Wendel EM, Lechner C, Baumann M, Mariotto S, Ferrari S, Saiz A, Farrell M, Leite MIS, Irani SR, Palace J, Lutterotti A, Kümpfel T, Vukusic S, Marignier R, Waters P, Rostasy K, Berger T, Probst C, Höftberger R, Reindl M. Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases. Neurol Neuroimmunol Neuroinflamm 8(5):e1027.
  24. Steinhagen K, Borchardt-Lohölter V, Stiba K, Klemens JM, Lattwein E, Saschenbrecker S, Schlumberger W. Serological detection of specific IgA antibodies against Zika virus nonstructural protein 1 contribues to diagnosis of acute Zika virus infections. In: Martin CR et al. (Hrsg.): Zika virus impact, diagnosis, control, and models. The Neuroscience of Zika virus. Elsevier Academic Press, Volume 2:293-302 (2021).
  25. Van Anh Pham C, Rademacher F, Hinrichs H, Beck-Jendroschek V, Harder M, Brasch J, Gläser R, Harder J. Expression of epidermal antimicrobial peptides is increased in tinea pedis. Mycoses 64(7):763-770 (2021).
  26. Weisser H, Steinhagen K, Höcker R, Borchardt-Lohölter V, Anvari Ö, Kern PM. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs. Clin Chem Lab Med 59(5):979-985 (2021).
  27. Wilke JBH, Hindermann M, Berghoff SA, Zihsler S, Arinrad S, Ronnenberg A, Barnkothe N, Steixner-Kumar AA, Röglin S, Stöcker W, Hollmann M, Nave KA, Lühder F, Ehrenreich H. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Mol Psychiatry doi: 10.1038/s41380-021-01238-3 (2021).
  1. Alessio MG, Previtali G, Agatea L, Favaro E, de Gaspari P, Novel P, Confettura A, Dilberger B, Wenderoth A, Herbst V. A new chemiluminescence immunoassay for the detection of faecal calprotectin. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  2. Braasch J, Ostermann S, Mackiewicz M, Borchardt-Lohölter V, Lattwein E, Schlumberger W. New approach for the detection of Trichinella spiralis in slaughtered pigs.29th Annual Meeting of the German Society for Parasitology, virtueller Kongress (2021).
  3. Dieckmann K, Menge B, KlemensO, Klemens JM, Saschenbrecker S, Jittmittraphap A, Leaungwutiwong P, Steinhagen K. Added value of testing for specific serum IgA additionally to IgM in acute secondary dengue virus infections. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), virtueller Kongress (2021).
  4. Dilberger B, Sabalza M, Schlumberger W, Dähnrich C. Increased sensitivity for detection of IgA autoantibodies against tissue transglutaminase using a new chemiluminescence immunoassay. 34th Meeting of Medical Laboratory Immunologists (AMLI), Austin, USA (2021).
  5. Dilberger B, Sabalza M, Schlumberger W, Dähnrich C. Increased sensitivity for detection of IgA autoantibodies against tissue transglutaminase using a new chemiluminescence immunoassay. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  6. Dilberger B, Schlumberger W, Dähnrich C. Increased sensitivity for detection of IgA autoantibodies against tissue transglutaminase using a new chemiluminescence immunoassay. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  7. Feng X, Liu Y, Karl I, Ott A, Scheper T, Meyer W, Yan HP. Diagnostic value of autoantibodies against D-3-phosphoglycerate dehydrogenase (PGDH) among patients with liver diseases. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  8. Filippis C, Binder F, Lickfeld M, Schröder AK, Klemens JM, Saschenbrecker S, Steller U. Novel PCR test to differentiate between infections with SARS-CoV-2, Influenza A and B. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), virtueller Kongress (2021).
  9. Filippis C, Binder F, Lickfeld M, Schröder AK, Klemens JM, Saschenbrecker S, Steller U. Novel PCR test to differentiate between infections with SARS-CoV-2, Influenza A and B. 8th Internationsl Meeting on Emerging Diseases and Surveillance (IMED), virtueller Kongress (2021).
  10. Goletz S, Karl I, Probst C, Komorowski L, Schlumberger W, Zilikens D, Stöcker W, Schmidt E. Cell-based immunofluorescence test applying recombinant laminin 332 for the serological diagnosis of pemphigoid. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  11. Goletz S, Probst C, Komorowski L, Schlumberger W, Zillikens D, Stöcker W, Schmidt E. Cell-based immunofluorescence test applying recombinant laminin 332 for the serological diagnostics of pemphigoid. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  12. Goletz S, Venkataraman I, Karl I, Probst C, Komorowski L, Schlumberger W, Zilikens D, Stöcker W, Schmidt E. Cell-based immunofluorescence test applying recombinant laminin 332 for the serological diagnosis of pemphigoid. 34th Meeting of Medical Laboratory Immunologists (AMLI), Austin, USA (2021).
  13. Goletz S, Venkataraman I, Karl I, Probst C, Komorowski L, Schlumberger W, Zilikens D, Stöcker W, Schmidt E. Cell-based immunofluorescence test applying recombinant laminin 332 for the serological diagnosis of pemphigoid. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  14. Hoffmann K, Dieckmann K, Klemens JM, Saschenbrecker S, Herbst V. Novel antigen assay for acute diagnostics of COVID-19 in the laboratory. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), virtueller Kongress (2021).
  15. Hoffmann K, Dieckmann K, Klemens JM, Saschenbrecker S, Herbst V, Sabalza M. Novel antigen assay for acute diagnostics of COVID-19 in the laboratory. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  16. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Lennaon VA, Komorowski L, Scharf M, Stöcker W, Hinson SR, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein 3B2-IgG. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  17. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Lennaon VA, Komorowski L, Venkataraman I, Scharf M, Stöcker W, Hinson SR, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein 3B2-IgG. 34th Meeting of Medical Laboratory Immunologists (AMLI), Austin, USA (2021).
  18. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Lennaon VA, Komorowski L, Venkataraman I, Scharf M, Stöcker W, Hinson SR, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein 3B2-IgG. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  19. Hoxha E, Stahl RAK, Brix SR, Venkataraman I, Witte T, Brock J, Schlumberger W, Daehnrich C. Increased sensitivity for PR3-ANCA using a novel chemiluminescence immunoassay. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  20. Hoxha E, Stahl RAK, Brix SR, Witte T, Brock J, Schlumberger W, Daehnrich C. Increased sensitivity for PR3-ANCA using a novel chemiluminescence immunoassay. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  21. Hoxha E, Stahl RAK, Reinhard L, Kühnl A, Burmeister Y, Saschenbrecker S, Schlumberger W, Dähnrich C. A new chemiluminescence immunoassay for phospholipase A2 receptor 1 autoantibodies allows earlier identification of relapses in patients with membranous nephropathy. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  22. Hoxha E, Stahl RAK, Reinhard L, Kühnl A, Burmeister Y, Saschenbrecker S, Schlumberger W, Dähnrich C. A new chemiluminescence immunoassay for phospholipase A2 receptor 1 autoantibodies allows earlier identification of relapses in patients with membranous nephropathy. 13. Jahrestagung der Deutschen Gesellschaft für Nephrologie (DGfN), Rostock, Germany (2021).
  23. Hoxha E, Stahl RAK, Reinhard L, Sabalza M, Kühnl A, Burmeister Y, Saschenbrecker S, Schlumberger W, Dähnrich C. A new chemiluminescence immunoassay for phospholipase A2 receptor 1 autoantibodies allows earlier identification of relapses in patients with membranous nephropathy. 34th Meeting of Medical Laboratory Immunologists (AMLI), Austin, USA (2021).
  24. Janz J, Ott A, Lindae A, Scheper T, Schlumberger W, Meyer W. Multiparameter assay for the detection of IgA antibodies in autoimmune gastrointestinal disease. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  25. Janz J, Ott A, Lindae A, Scheper T, Schlumberger W, Meyer W. Multiparameter assay for the detection of IgG antibodies in autoimmune gastrointestinal disease. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  26. Janz J, Ott A, Richter M, Scheper T, Schlumberger W, Meyer W. Addition of cN-1A as a target for detection of autoantibodies associated with Inclusion Body Myositis to a multiparameter lineblot immunoassay for autoimmune inflammatory myopathies. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  27. Janz J, Ott A, Richter M, Scheper T, Schlumberger W, Meyer W. Addition of cN-1A as a target for detection of autoantibodies associated with Inclusion Body Myositis to a multiparameter lineblot immunoassay for autoimmune inflammatory myopathies. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  28. Kühnl A, Burmeister Y, Sabalza M, Saschenbrecker S, Komorowski L, Probst C, Pesce G, Schlumberger W, Dähnrich C. Novel Anti-ATP4B ELISA to aid the diagnosis of autoimmune gastritis. 34th Meeting of Medical Laboratory Immunologists (AMLI), Austin, USA (2021).
  29. Kühnl A, Burmeister Y, Sabalza M, Saschenbrecker S, Komorowski L, Probst C, Pesce G, Schlumberger W, Dähnrich C. Novel Anti-ATP4B ELISA to aid the diagnosis of autoimmune gastritis. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  30. Kühnl A, Burmeister Y, Saschenbrecker S, Komorowski L, Probst C, Pesce G, Schlumberger W, Dähnrich C. Novel Anti-ATP4B ELISA to aid the diagnosis of autoimmune gastritis. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  31. Langer N, Wilken D, Klemens O, Dolscheid-Pommerich R, Renn M, Streeck H, Kümmerer BM, Schulte B, Frank K, Karl A, Klemens JM, Saschenbrecker S, Hartmann G, Steinhagen K. Correlation between quantitative anti-SARS-CoV-2 IgG ELISA and neutralization tests. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), virtueller Kongress (2021).
  32. Markewitz R, Pauli D, Dargvainiene J, Steinhagen K, Engel S, Herbst V, Zapf D, Krüger C, Sharifzadeh S, Schomburg B, Leypoldt F, Rupp J, Görg S, Junker R, Wandinger KP. No evidence for short-term induction of antinuclear antibodies by vaccination with BNT162b2 and mRNA-1273. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  33. Menge B, Klemens JM, Mentz J, Dieckmann K, Saschenbrecker S, Tran KH, Hetherington M, Steinhagen K. Sensitive detection of antibodies in patients with acute Coxiella burnetii infection. World Microbe Forum, Congress of the American Society for Microbiology (ASM) and the Federation of European Microbiological Societies (FEMS), virtueller Kongress (2021).
  34. Menge B, Klemens JM, Mentz J, Dieckmann K, Saschenbrecker S, Tran KH, Hetherington M, Steinhagen K. Sensitive detection of antibodies in patients with acute Coxiella burnetii infection. 8th Internationsl Meeting on Emerging Diseases and Surveillance (IMED), virtueller Kongress (2021).
  35. Miske R, Mindorf S, Ott A, Borowski K, Jäger D, Honnorat J, McKeon A, Teegen B, Probst C, Komorowski L. Detection of anti-AK5 autoantibodies in patients with limbic encephalitis by indirect immunofluorescence assay and line blot. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  36. Miske R, Scharf M, Hahn S, Denno Y, Benkhadra F, Rochow N, Probst C, Teegen B, Stöcker W, Komorowski L. Identification of DAGLA as an autoantibody target in cerebellar or hippocampal degeneration. 12th International Congress on Autoimmunity (ICA), virtueller Kongress (2021).
  37. Miske R, Venkataraman I, Scharf M, Hahn S, Denno Y, Benkhadra F, Rochow N, Probst C, Teegen B, Stöcker W, Komorowski L. Identification of DAGLA as an autoantibody target in cerebellar or hippocampal degeneration. 34th Meeting of Medical Laboratory Immunologists (AMLI), Austin, USA (2021).
  38. Miske R, Venkataraman I, Scharf M, Hahn S, Denno Y, Benkhadra F, Rochow N, Probst C, Teegen B, Stöcker W, Komorowski L. Identification of DAGLA as an autoantibody target in cerebellar or hippocampal degeneration. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  39. Ott A, Scharf M, Miske R, Jäger D, Honnorat J, Komorowski L, Scheper T, Meyer W. Parallel detection of antibodies against CDR2L and CDR2 increases the diagnostic specificity in serological diagnostics of paraneoplastic cerebellar degeneration. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  40. Pollmann M, Klemens O, Klemens JM, Saschenbrecker S, Steinhagen K. Development of a novel NS1-based ELISA for the detection of specific IgG antibodies against Japanese encephalitis virus. 23nd Annual Meeting of the European Society for Clinical Virology (ESCV), virtueller Kongress (2021).
  41. Pollmann M, Ott A, Liefeld M, Borchardt-Lohölter V, Scheper T, Meyer W. Novel line blot differentiates between IgG antibodies against three SARS-CoV-2 antigens and against further seasonal coronaviruses. 23nd Annual Meeting of the European Society for Clinical Virology (ESCV), virtueller Kongress (2021).
  42. Schäfer J, Menge B, Dibbern J, Borchardt-Lohölter V, Steinhagen K, Schlumberger W. Novel ELISA based on purified and recombinant antigens from Toxocara canis exhibits a high diagnostic sensitivity. 29th Annual Meeting of the German Society for Parasitology, virtueller Kongress (2021).
  43. Schäfer J, Menge B, Stiba K, Dibbern J, Borchardt-Lohölter V, Steinhagen K, Schlumberger W. Novel ELISA based on purified and recombinant antigens from Toxocara canis exhibits a high diagnostic sensitivity. 8th Internationsl Meeting on Emerging Diseases and Surveillance (IMED), virtueller Kongress (2021).
  44. Scharf M, Miske R, Denno Y, Probst C, Jäger D, Borowski K, Teegen B, Komoroski L. Strategy for the detection of anti-septin antibodies by indirect immunofluorescence assay. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  45. Stiba K, Menge B, KlemensO, Klemens JM, Saschenbrecker S, Jittmittraphap A, Leaungwutiwong P, Steinhagen K. Added value of testing for specific serum IgA additionally to IgM in acute secondary dengue virus infections. 23nd Annual Meeting of the European Society for Clinical Virology (ESCV), virtueller Kongress (2021).
  46. Stiba K, Klemens O, Pollmann M, Klemens JM, Saschenbrecker S, Steinhagen K. Development of a novel NS1-based ELISA for the detection of specific IgG antibodies against Japanese encephalitis virus. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), virtueller Kongress (2021).
  47. Van Beers J, Damoiseaux J, Jobsen M, Dähnrich C, Kühnl A, Schlumberger W. Routine application of PR3- and MPO-ANCA chemiluminescence immunoassays demonstrates enhanced detection rates. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  48. Venkataraman I, Pollmann M, Ott A, Liefeld M, Borchardt-Lohölter V, Scheper T, Meyer W. Novel line blot differentiates between IgG antibodies against three SARS-CoV-2 antigens and against further seasonal coronaviruses. AACC Annual Scientific Meeting & Clinical Lab Expo, Atlanta, USA (2021).
  49. Villalta D, Alessio MG, Previtali G, Infantino M, Manfredi M, Agatea L, Favaro E, Kühnl A, Dähnrich C, Schlumberger W. Novel chemiluminescence immunoassays for serological diagnostics of coeliac disease. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  50. Vink C, van de Logt AE, Kühnl A, Dähnrich C, Schlumberger W, Wetzels J. Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome using cyclophosphamide and sterods treatment in patients with membranous nephropathy. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  51. Weisser H, Steinhagen K, Höcker R, Borchardt-Lohölter V, Anvari Ö, Kern PM. Dried blood spots: a robust sample material for detection of anti-SARS-CoV-2 antibodies. Valuable tool in the context for seroprevalence and vaccination studies. 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), virtueller Kongress (2021).
  52. Weisser H, Steinhagen K, Höcker R, Borchardt-Lohölter V, Anvari Ö, Kern PM. Dried blood spots are an alternative sampling material for detection of anti-SARS-CoV-2 antibodies. 30th Annual Meeting of the Society for Virology (GfV), virtueller Kongress (2021).
  53. Wolf J, Rockstroh A, Kalbitz S, Pollmann M, Rosenstock P, Steinhagen K, Borte S. Correlation between binding and neutralising antibodies against SARS-CoV-2 with respect to the severity and phase of COVID-19. 23nd Annual Meeting of the European Society for Clinical Virology (ESCV), virtueller Kongress (2021).
  54. Zeng Z, Miske R, Scharf M, Denno Y, Probst C, Teegen B, Ott A, Komorowski L. Identification of NVL as a novel ANA target in systemic sclerosis. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  1. Braasch J. A new approach for accurate detection of Trichinella spiralis in slaughtered pigs. Tagung der DVG Fachgruppe "Parasitologie und parasitäre Krankheiten", virtueller Kongress (2021).
  2. Braasch J. A new approach for sample preparation and objective detection of specific Trichinella spiralis antigens using a chemiluminescence immunoassay. 28th International Conference of the World Association for the Advancement of Veterinary Parasitology, virtueller Kongress (2021).
  3. Burmeister Y. Serological and urinary diagnostics of different autoimmune nephropathies, 42 Congreso Nacional de la Sociedad Española de Inmunología (SEI), virtueller Kongress (2021).
  4. Dieckmann K. Beyond COVID-19 vaccination – Testing the humoral and cellular immune response. Webinar EUROIMMUN Asia: “Dynamics of immune response against SARS-CoV-2” (2021).
  5. Ens K. Automation and Artificial Intelligence in Diagnostic Immunofluorescence Microscopy using EUROPattern. Omnia Health Webinar (2021).
  6. Komorowski L. Detection methods and strategies for novel neuronal autoantibodies. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  7. Krauth J. Artificial intelligence: automated immunofluorescence pattern recognition 2.0. 15th Dresden Symposium on Autoantibodies, Dresden, Germany (2021).
  8. Lindae A. Challenges of serological autoimmune diagnostics with focus on systemic sclerosis. INOCHEM (Mexico) Autoimmunity Workshop, virtueller Beitrag (2021),
  9. Wetzel S. Ganz schön ausgefuchst! – Zuverlässige Allergiediagnostik mit Multiparametertests von EUROIMMUN, Qualitätszirkel der Lübecker HNO-Ärzte (2021).
  10. Zonta MA. Prevalences of STI and HPV in a women´s prison in the state capital of Sao Paulo, Brazil. Congress of the European Research Organization on Genital Infection and Neoplasia (EUROGIN), virtueller Kongress (2021).
  1. Becker A, Schoch McGovern S. Detection of an autoantibody. Europäische und US-Patentanmeldung EP3786641 (angemeldet 2020) und US2021/0063393A1 (angemeldet 2020).
  2. Bernitt E, Feirer C, Rateike M, Stöcker W, Schwab S. Vorrichtung und Verfahren zur Identifikation von Deckglasbereichen eines Objektträgers. Europäische und Internationale Patentanmeldung EP3839596 (angemeldet 2019) und WO2021/122888 (angemeldet 2020).
  3. Dähnrich C, Konitzer S. An improved autoantibody detection assay. Internationale Patentanmeldung WO2021/023836 (angemeldet 2020).
  4. Dettmann IM, Stegelmann C, Probst C, Radzimski C, Mindorf S. Method for the detection of autoantibody to acetylcholine receptor. Europäische und Singapurische Patentanmeldung EP3842802 (angemeldet 2020) und 10202012737T (angemeldet 2020).
  5. Filippis C, Steller U, Schilling F. Verfahren zur qualitativen Auswertung von Real-Time PCR Daten. Europäische und Internationale Patentanmeldung EP3839958 (angemeldet 2019) und WO2021/123171 (angemeldet 2020).
  6. Hagen-Eggert M, Sumpf TJ. Verfahren und Mikroskopiersystem zum Aufnehmen eines mikroskopischen Fluoreszenzbildes eines Probenbereiches mit einer biologischen Probe. Brasilianische Patentanmeldung BR102019026948-0 (angemeldet 2019).
  7. Harder M, Gräser Y, Kupsch C, Cavalar M. Assay for the diagnosis of dermatophytosis. Australische und US-Patentanmeldung 2018202209 (angemeldet 2018) und US2021/0254184A1 (angemeldet 2021).
  8. Krauth J, Krause C, Voigt J, Hahn M, Marzahl C, Gerlach S. Detektion von Präsenzen unterschiedlicher antinukleärer Antikörper-Fluoreszenzmustertypen und Vorrichtung hierfür. Europäische, Chinesische und US-Patentanmeldung EP3767587 (angemeldet 2019), CN112240878A (angemeldet 2020) und US2021/0019883A1 (angemeldet 2020).
  9. Marzahl C, Gerlach S, Voigt J, Kröger C. Bildverarbeitungsverfahren zum Anzeigen von Zellen mehrere Gesamtbilder. Europäische und US-Patentanmeldung EP3876193 (angemeldet 2020) und US2021/0272279 (angemeldet 2021).
  10. Miske R, Scharf M, Komorowski L, Denno Y, Hahn S, Radzimski C, Unger M, Mayo Clinic. Diagnosis of neurological disease. Europäische und US-Patentanmeldung EP3839511 (angemeldet 2020) und US2021/0181196A1 (angemeldet 2020).
  11. Morgenroth K, Viertel V, Steller U, Gerlach S, Marzahl C, Voigt J, Stöcker W. Verfahren zum automatisierten Detektieren von Antikörpern in einer flüssigen biologischen Probe unter Verwendung eines Antigen-Chips und Antigen-Chip hierfür / Method for automated detection of antibodies in a liquid biological sample using an antigen chip, and antigen chip therefore. Chinesische, Brasilianische und US-Patentanmeldung CN112334775A (angemeldet 2019), BR112020023867-8 (angemeldet 2019) und US2021/0245152A1 (angemeldet 2019).
  12. Menge B, Steinhagen K, Schaefer J, Probst C, Deerberg A, Unger M, Messing C. A novel assay for the diagnosis of nematode infections. Europäische, Chinesische und US-Patentanmeldung EP3761029 (angemeldet 2020), CN112180096A (angemeldet 2020) und US2021/0003591A1 (angemeldet 2020).
  13. Probst C, Mindorf S, Dettmann IM. Improved detection of NMDA receptor autoantibodies. Internationale Patentanmeldung WO2021/048263 (angemeldet 2020).
  14. Rolf A, Stahl K, Hoxha E, Eisenmann J, Reinhard L. A method and reagents for the diagnosis of MN. Internationale Patentanmeldung WO2021/023816 (angemeldet 2020).
  15. Steinhagen K, Deerberg A, Lattwein E, Radzimski C, Böthfür J. An immunoassay for the diagnosis of viral infections. US-Patentanmeldung US2021/0033609A1 (angemeldet 2017).
  16. Steinhagen K, Messing C, Lattwein E, Stiba K, Lindhorst F, Neugebauer E, Charité - Universitätsmedizin Berlin. Methods and reagents for diagnosis of SARS-CoV-2 infection. Europäische, Belgische, Britische, Deutsche, Französische, Italienische, Niederländische, Österreichische, Polnische, Schweizer, Spanische, Tschechische Patentanmeldung 3809137 (angemeldet 2021).
  17. Steinhagen K, Messing C, Lattwein E, Stiba K, Lindhorst F, Neugebauer E, Charité - Universitätsmedizin Berlin. Methods and reagents for diagnosis of SARS-CoV-2 infection. Internationale, Kanadische und US-Patentanmeldung WO2021/165448 (angemeldet 2021), CA3109607A1 (angemeldet 2021) und US2021/0190797A1 (angemeldet 2021).
  18. Stöcker W, Komorowski L, Steinhagen K. A method for determining the efficacy of a vaccine. Europäische Patentanmeldung EP3855186 (angemeldet 2021).
  19. Noch nicht bekannt. Assessing and treating autoimmune ataxia. Europäische Patentanmeldung EP3819156 (angemeldet 2019).
  20. Noch nicht bekannt. A method and reagents for the diagnosis of SARS-CoV-2. Europäische Patentanmeldung EP3869199 (angemeldet 2020) und EP3869200 (angemeldet 2020).
Back to top